Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, today announced the close of an oversubscribed $23 million Series A financing to further advance its novel ...

AI company unlocking causal human biology, today presented new preclinical data from its metabolic dysfunction-associated steatohepatitis (MASH) therapeutic development program during a podium ...

Yeast’s emergence as a model organism reshaped scientific discovery in cell biology, genetics, and more.

Enduro Genetics, a synthetic biology startup, raised €12 million ($12.4 million) in Series A funding from Supernova Invest, NOON Ventures, and Sandwater. The funding will be used to expand Enduro’s ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.

Engage Biologics Inc. ("Engage"), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company ("Lilly").

Researchers at Cornell University have developed a safer and more precise way to study how genes function in living tissues by refining a recently developed CRISPR-based genetic technique in fruit ...

A graph-based computational tool for detecting previously invisible genetic mutations has been developed. Researchers at the University of California, Los Angeles (UCLA; USA) and the University of ...

Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is ...